MOUNJARO KwikPen (Tirzepatide) 2.5 mg/0.6 mL

Uses of Tirzepatide 2.5 mg

• Initial starting dose for adults with type 2 diabetes
• Helps improve blood sugar control
• Supports gradual treatment initiation
• Used alongside a healthy diet and regular exercise
• Prepares patients for higher maintenance doses

Benefits of Tirzepatide 2.5 mg

• Helps begin diabetes treatment safely
• Improves blood sugar management
• Once-weekly injection for convenience
• Allows gradual dose adjustment
• May help reduce appetite

How Does Tirzepatide 2.5 mg Work?

Tirzepatide 2.5 mg works by activating both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. It increases insulin release when blood sugar levels are high, reduces glucagon secretion, slows stomach emptying, and helps decrease appetite. The 2.5 mg dose is intended to help the body adjust to treatment before increasing to maintenance doses.

Side Effects of Tirzepatide 2.5 mg

• Nausea
• Vomiting
• Diarrhoea
• Constipation
• Decreased appetite
• Stomach discomfort
• Indigestion
• Injection-site reactions

Precautions

• Use only as prescribed by your healthcare provider.
• The 2.5 mg dose is for treatment initiation and is not intended for long-term blood sugar control.
• It is not recommended for people with type 1 diabetes.
• Inform your doctor if you have a history of pancreatitis.
• Tell your healthcare provider about any kidney or liver problems.
• Discuss its use with your doctor if you are pregnant, planning a pregnancy, or breastfeeding.
• Monitor your blood sugar regularly and follow the recommended dose-escalation schedule.